Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
MFN.se > Medivir > FDA grants Medivir´s MIV-711 Orphan Drug Designation ...
Medivir Secures $3 Million Investment for Innovative Cancer Drug ...
Medivir hopes new CEO can kick-start clinical development ...
Medivir aktie | MVIR | Aktiekurs, analyser & nyheter
Logotipo De Medivir
Medivir - Wikiwand
PPT - This is MEDIVIR PowerPoint Presentation, free download - ID:4034699
PPT - Medivir in Brief PowerPoint Presentation, free download - ID:332817
Medivir have agreed with Lonza to manufacture a fostrox GMP campaign ...
Medivir provides update from supportive Type C meeting with the FDA ...
Medivir presents new data at AACR showing significantly improved ...
Medivir launches Olysio in the Nordic countries
Medivir AB: FDA grants Medivir's MIV-711 Orphan Drug Designation for ...
Medivir licenses respiratory syncytial virus drug program
FDA accepts Medivir IND application - Nordic Life Science – the leading ...
Beactica and Medivir in drug discovery collaboration
Medivir Licenses Exclusive Rights to MIV-802 for Greater China to ...
Medivir får särläkemedelsstatus från FDA
Medivir comments on orphan drug status and progress in partnerships ...
Medivir appoints Vice President Clinical Development - Nordic Life ...
Medivir continues to accelerate development with fostrox - Biostock
MVIR | Medivir provides update from supportive Type C meeting with the ...
PPT - Medivir AB Acumen BioFin 4th Annual Global Healthcare Conference ...
Medivir (MVIR) osake | Nordnet
Medivir starts patient dosing in phase 2a study of fostrox in ...
Quotient Sciences supports Medivir with updated formulation of fostrox ...
Medivir announces improved durable clinical benefit with fostrox - Biostock
Cancer Research Technology and Medivir collaborate to develop new class ...
Medivir & TetraLogic Partnership: What You Need To Know - Healthcare Weekly
Medivir announces Phase II data - NLS
Medivir : FDA grants Medivir´s MIV-711 Orphan Drug Designation for the ...
Medivir | Stockholm, Sweden
Medivir licenses preclinical USP7 program to Ubiquigent - Microbioz India
#hepatocellularcarcinoma #fostrox | Medivir AB
Medivir - Healthcare Webinar - YouTube
Medivir Blue, Logotipo, Hepatite C, Vacina contra Hepatite C ...
Q2 marked continued progress for Medivir in advanced liver cancer ...
Medivir - Interview with CEO Yilmaz Mahshid - YouTube
Medivir gets new CEO
Medivir announces Phase II data - Nordic Life Science – the leading ...
Medivir and Janssen in dengue fever research alliance - Pharmafile
With expertise in delivering drugs to the liver, Medivir recently had ...
ABGSC assisted Medivir in raising total proceeds of approximately SEK ...
Medivir Set to Showcase Fostrox and Lenvima Data at ESMO - Investors ...
Medivir presenterar vid Pareto Securities Healthcare Conference ...
FDA Grants Medivir AB´S MIV-711 Rare Pediatric Disease Designation for ...
Medivir AB recently announced that it has finalized the development of ...
Medivir gör riktad nyemission på 45 miljoner till Carl Bennet
Medivir - I en starkare position | Carnegie Access
Medivir presents promising results in difficult-to-treat patient ...
Medivir clears key hurdles ahead of phase IIb - Biostock
Preliminary results from Medivir Phase 2a study - Nordic Life Science ...
Nyemission i Medivir AB på Nasdaq Stockholm - Aktier
PharmaShots on LinkedIn: Medivir AB Reports the First Patient Dosing of ...
Accessbolaget Medivir AB - En till pusselbit på rätt plats. Läs den ...
MEDIVIR – Narouva
Carl Bennet AB becomes major shareholder in Medivir | Medivir AB
Medivir i möte med FDA: "Positiv återkoppling"
Medivir & Karo Pharma’s deal; Astellas acquires Ganymed
Large interest in the Medivir AB poster at EASL liver cancer summit in ...
Swedish pharma firm Medivir partners GVK Bio for drug research, ET ...
Cord Communications - Investor Day 2024 Medivir | Medivir AB
Medivir AB revenue 2025| Statista
MAESTrO: FDA grants Medivir´s MIV-711 rare paediatric disease ...
Medivir将在EASL肝癌峰会上展示临床药代动力学数据，进一步支持fostrox的持续开发-动脉网
Home - Health U Fit
Medivir—focusing on cancer one prodrug at a time
PPT - Medivir: Leading Innovations in Polymerase and Protease Research ...
In a phase 2a research using Lenvima and fostrox to treat ...
PPT - Medivir's Transformation: From Biotech to Pharma with Innovative ...
PPT - Innovations in Infectious Disease Treatment: Medivir's 2011 ...
PPT - One focused pipeline March 2010 PowerPoint Presentation, free ...
PPT - Medivir: Swedish Biotech Transforming into a Pharmaceutical ...
PPT - Presentation Spring 2004 medivir.se PowerPoint Presentation, free ...
PPT - Selling and Marketing Pharmaceuticals in the Nordic Region ...
Medivir’s nucleotide polymerase inhibitor for the treatment of liver ...
FDA grants Medivir's MIV-711 Orphan Drug Designation - NLS
Medivir, Daewoong end hepatitis drug development
Drug Discovery and Development Platform at SciLifeLab to collaborate ...
USP7 inhibitors (Medivir) - Drug Targets, Indications, Patents - Synapse
Transactions - Zonda Partners
Hard work by a fantastic team has paid off and we are one step closer ...
Noterade bolag | Linc
Congratulations to our partner Tango Therapeutics with their ...
Good news today as we continue our preparations for upcoming phase 2b ...
Credentials : Pareto Securities
Medivir’s partner Infex Therapeutics signs a license agreement for the ...
Medivir’s CTCL drug remetinostat yields positive data in phase II study ...
February 21 2023
Medivir: "Med den här kombinationen ligger vi längst fram" - Biostock
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and ...
Basal Cell Carcinoma Market to Grow at a Substantial Growth Rate ...
Medivir's fostrox + Lenvima confirm promise of improved outcomes in ...
Sweden based pharma firm enters into partnership with GVK Bio for drug ...
Medivir's Phase Ib/IIa study successfully completed - Biostock
Medivir's CMO: "Our new clinical data are very encouraging" - Biostock
หุ้น MVRBF งบการเงิน 10 ปี พร้อมกราฟ - Finnomena
Lonza to Manufacture Medivir’s Fostrox Drug Substance | Pharmaceutical ...
Medivir's CEO: "Fostrox is unique in its kind" - Biostock
